02135.HK
Raily Aesthetic Medicine International Holdings Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 0.12
+14.29%Year over year
Reported trailing growth
- Revenue
- +30.9%
- EBITDA
- +842.7%
- EBIT
- +160.4%
- EPS
- +120.6%
- Free cash flow
- -63.0%
- Operating cash flow
- +167.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.9%
- EBITDA
- +90.6%
- EBIT
- +127.0%
- Net income
- +103.1%
- EPS
- +100.5%
- Free cash flow
- +183.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026